Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

Clinical trial NCT07494435 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07494435
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)Renal Cell Cancer

Start date: 2026-06-01
Primary completion: 2028-06-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.